im Fokus

Meet the experts: a new therapy option for SLE

Livestream bis

We cordially invite you to our WebUp in focus on «Meet the experts: a new therapy option for SLE».

Look forward to an exciting WebUp on Systemic Lupus Erythematosus (SLE), meet the experts Prof. Dr. Johannes von Kempis (Clinic Director, Rheumatology clinic, Kantonsspital St. Gallen), Prof. Dr. Camillo Ribi (Médecin-Chef, Division of Immunology and Allergy, CHUV, Lausanne), Prof. Dr. Marta Mosca (Rheumatology Unit Director, Universita’ di Pisa, Italy) and Prof. Dr. Edward Vital (Associate Professor in Systemic Lupus Erythematosus at University of Leeds, United Kingdom). 

We look forward to interesting questions and a lively discussion.

Participation in the WebUp is free of charge!
 

Für Livestream oder Zugriff auf On-Demand Inhalte brauchen Sie ein FomF Konto.

Referent/innen

Profile picture for user 00114564

Prof. Dr. med. Johannes von Kempis

Rheumatologie

Profile picture for user 00003763

Prof. Dr. med. Camillo Ribi

Allergologie und klinische Immunologie

Profile picture for user 00114565

Prof. Dr. med. Marta Mosca

Rheumatologie

Profile picture for user 00114566

Prof. Dr. med. Edward Vital

Rheumatologie

Content

The goal of this WebUp is to inform you about the most important clinical study and real world data on Anifrolumab and to show you the significance of this new therapeutic option in SLE. 

Join the Swiss and international SLE experts! Prof. von Kempis (KSSG) will chair the WebUp and Prof. Ribi (CHUV) will introduce Anifrolumab and the most important clinical studies. Prof. Mosca (University of Pisa, Italy) and Prof. Vital (University of Leeds, United Kingdom) will share their vision and their real world experiences with IFN I inhibition,  Anifrolumab therapy and discuss some patient cases with you. Afterwards, we look forward to your interesting questions and having a lively discussion with you.

18.00-18.05    Opening
                       Prof. Johannes von Kempis 

18:05-18:25    Clinical Study Update on Anifrolumab in SLE
                       Prof. Camillo Ribi

18.25-18.45    IFN blockade in SLE: a scientific rationale and clinical experience
                       Prof. Edward Vital

18.45-19.05    Anifrolumab in patients with SLE: preliminary single center experience
                       Prof. Marta Mosca

19:05-19:25    Q&A Discussion
                       Prof. Johannes von Kempis

19.25-19.30    Closing remarks
                       Prof. Johannes von Kempis

Target group

Rheumatologists, Immunologists, Nephrologist and other interested specialists.

In friendly cooperation with

AstraZeneca

General informations

  • This broadcast is made available to you free of charge. To view the broadcast, click on «Login» before the broadcast starts and log in with your FomF account. If you do not have an account yet, you can create one by clicking on «Register».
     

  • By clicking on «Termin vormerken» you will receive an e-mail 3 hours before the start of the broadcast and / or, if you wish, an SMS reminder 15 minutes before the start of the broadcast.
     

  • To ask questions during the broadcast, please click on the speech bubble at the bottom right of the screen & you will be able to ask your questions in the chat room.
     

  • Missed the broadcast? No problem, after 24 hours the recording of the broadcast will be available for you on this page OnDemand.
     

  • If you have technical questions about the stream, please visit our FAQ page.